posted on 2025-02-13, 16:17authored byStephanie
M. Roser, Fabiola Munarin, Collin Polucha, Alicia J. Minor, Gaurav Choudhary, Kareen L. K. Coulombe
Therapeutic
protein delivery has ushered in a promising new generation
of disease treatment, garnering more recognition for its clinical
potential than ever. However, proteins’ limited stability,
extremely short average half-lives, and evidenced toxicity following
systemic delivery continue to undercut their efficacy. Biomaterial-based
protein delivery, however, demonstrates the potential to overcome
these obstacles. To this end, we have developed a heparinized alginate
and collagen hydrogel for the local, sustained delivery of therapeutic
proteins. In an effort to match this ubiquitous application of protein
delivery to various disease states and target tissues with sufficient
versatility, we identified three distinct delivery modes as design
targets. A shear-thinning, low-viscosity injectable for minimal tissue
damage, a higher-viscosity gel plug for subcutaneous injection, and
a submillimeter-thickness film for solid-form implantation were optimized
and characterized in this work. In vitro assessments confirmed feasible
injection control, mechanical stability for up to 6 h of unsubmerged
storage, and isotropic early collagen fibril assembly. Release kinetics
were assessed both in vitro and in vivo, demonstrating up to 14 days
of functional vascular endothelial growth factor delivery. Rodent
models of pulmonary hypertension, subcutaneous injection, and myocardial
infarction, three promising applications of protein therapeutics,
were used to assess the feasible delivery and biocompatibility of
the injectable gel, gel plug, and film, respectively. Histological
evaluation of the delivered materials and surrounding tissue showed
high biocompatibility with cell and blood vessel infiltration, remodeling,
and integration with the host tissue. Our successful customization
of the biomaterial to heterogeneous delivery modes demonstrates its
versatile capacity for the local, sustained delivery of therapeutic
proteins for a diverse array of regenerative medicine applications.